Ear-Zap therapy could spare kids from steroid side effects
NCT ID NCT05588063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a non-invasive device that gently stimulates a nerve in the ear to see if it can help control nephrotic syndrome in children aged 3-17. The goal is to reduce relapses and the need for steroids or other immune-suppressing drugs. Thirty children will be randomly assigned to receive either the real stimulation or a sham (fake) treatment to measure safety and effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19102, United States
-
Cohen Children's Medical Center
RECRUITINGNew Hyde Park, New York, 11040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney disease mystery: scientists launch massive data hunt
- Scientists hunt for genes behind kidney disease
- New drug aims to plug kidney leaks in multiple diseases
- New pill aims to plug protein leak in kidney patients
- Could less steroid be just as good for kids with kidney disease?
- New biobank aims to unlock why kidney disease returns after transplant